These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23995677)

  • 1. Serum angiopoietin-like protein 3 levels: possible correlation with progressive skin sclerosis, digital ulcers and pulmonary vascular involvement in patients with systemic sclerosis.
    Ichimura Y; Asano Y; Akamata K; Aozasa N; Noda S; Taniguchi T; Takahashi T; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Sato S; Kadono T
    Acta Derm Venereol; 2014 Mar; 94(2):157-62. PubMed ID: 23995677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of galectin-3: possible association with fibrosis, aberrant angiogenesis, and immune activation in patients with systemic sclerosis.
    Taniguchi T; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    J Rheumatol; 2012 Mar; 39(3):539-44. PubMed ID: 22247367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A possible contribution of elevated serum clusterin levels to the inhibition of digital ulcers and pulmonary arterial hypertension in systemic sclerosis.
    Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2012 Aug; 304(6):459-63. PubMed ID: 22350181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum soluble Tie1 levels in patients with systemic sclerosis.
    Noda S; Asano Y; Aozasa N; Akamata K; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Sumida H; Kuwano Y; Yanaba K; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2013 May; 305(4):325-31. PubMed ID: 23233281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum apelin levels: clinical association with vascular involvements in patients with systemic sclerosis.
    Aozasa N; Asano Y; Akamata K; Noda S; Masui Y; Yamada D; Tamaki Z; Tada Y; Sugaya M; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):37-42. PubMed ID: 22112232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum angiopoietin-like protein 3 concentrations in rheumatic diseases.
    Hayashi Y; Jinnin M; Makino T; Kajihara I; Makino K; Honda N; Nakayama W; Inoue K; Fukushima S; Ihn H
    Eur J Dermatol; 2012; 22(4):500-4. PubMed ID: 22652544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis.
    Miyagawa T; Asano Y; Saigusa R; Hirabayashi M; Yamashita T; Taniguchi T; Takahashi T; Nakamura K; Miura S; Yoshizaki A; Miyagaki T; Sato S
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):753-760. PubMed ID: 30520152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma soluble CD40 ligand concentrations in systemic sclerosis and association with pulmonary arterial hypertension and digital ulcers.
    Allanore Y; Borderie D; Meune C; Lemaréchal H; Weber S; Ekindjian OG; Kahan A
    Ann Rheum Dis; 2005 Mar; 64(3):481-3. PubMed ID: 15708899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian Scleroderma Research Group registry.
    Khimdas S; Harding S; Bonner A; Zummer B; Baron M; Pope J;
    Arthritis Care Res (Hoboken); 2011 Jan; 63(1):142-9. PubMed ID: 20740608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels of pentraxin 3 in systemic sclerosis: associations with vascular manifestations and defective vasculogenesis.
    Shirai Y; Okazaki Y; Inoue Y; Tamura Y; Yasuoka H; Takeuchi T; Kuwana M
    Arthritis Rheumatol; 2015 Feb; 67(2):498-507. PubMed ID: 25385504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum vaspin levels: A possible correlation with digital ulcers in patients with systemic sclerosis.
    Miura S; Asano Y; Saigusa R; Yamashita T; Taniguchi T; Takahashi T; Ichimura Y; Toyama T; Tamaki Z; Tada Y; Sugaya M; Sato S; Kadono T
    J Dermatol; 2015 May; 42(5):528-31. PubMed ID: 25708680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis.
    Toyama T; Asano Y; Takahashi T; Aozasa N; Akamata K; Noda S; Taniguchi T; Ichimura Y; Sumida H; Tamaki Z; Masui Y; Tada Y; Sugaya M; Sato S; Kadono T
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):337-44. PubMed ID: 22211766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.
    Nakamura K; Asano Y; Taniguchi T; Minatsuki S; Inaba T; Maki H; Hatano M; Yamashita T; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol; 2016 Aug; 43(8):912-8. PubMed ID: 26777734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
    Taniguchi T; Miyagawa T; Toyama S; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S; Asano Y
    Exp Dermatol; 2018 Sep; 27(9):1030-1037. PubMed ID: 29947047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of circulating platelet-activating factor acetylhydrolase levels in systemic sclerosis.
    Yanaba K; Asano Y; Tada Y; Sugaya M; Kadono T; Sato S
    Arch Dermatol Res; 2012 Apr; 304(3):203-8. PubMed ID: 22139405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbed balance between serum levels of receptor tyrosine kinases Tie-1, Tie-2 and angiopoietins in systemic sclerosis.
    Gerlicz Z; Dziankowska-Bartkowiak B; Dziankowska-Zaborszczyk E; Sysa-Jedrzejowska A
    Dermatology; 2014; 228(3):233-9. PubMed ID: 24603462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital ulcers predict a worse disease course in patients with systemic sclerosis.
    Mihai C; Landewé R; van der Heijde D; Walker UA; Constantin PI; Gherghe AM; Ionescu R; Rednic S; Allanore Y; Avouac J; Czirják L; Hachulla E; Riemekasten G; Cozzi F; Airò P; Cutolo M; Mueller-Ladner U; Matucci-Cerinic M;
    Ann Rheum Dis; 2016 Apr; 75(4):681-6. PubMed ID: 25688073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of serum decoy receptor 3 levels in patients with systemic sclerosis.
    Yamada D; Asano Y; Takahashi T; Masui Y; Aozasa N; Akamata K; Noda S; Tamaki Z; Tada Y; Sugaya M; Sato S; Kadono T
    Eur J Dermatol; 2012; 22(3):351-7. PubMed ID: 22456116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible association of elevated serum collagen type IV level with skin sclerosis in systemic sclerosis.
    Motegi SI; Sekiguchi A; Fujiwara C; Toki S; Ishikawa O
    J Dermatol; 2017 Feb; 44(2):167-172. PubMed ID: 27568491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.